Fort Baker Capital Management’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-245,000
Closed -$20.5K 111
2023
Q1
$20.5K Hold
245,000
﹤0.01% 80
2022
Q4
$1.25K Hold
245,000
﹤0.01% 88
2022
Q3
$30K Hold
245,000
﹤0.01% 83
2022
Q2
$25K Buy
+245,000
New +$50K ﹤0.01% 95

Fort Baker Capital Management's LVACW Position: Q2 2023 in Review

Fort Baker Capital Management sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 245,000 shares — an estimated $20.5K sold.

Fort Baker Capital Management first reported a position in LVACW in Q2 2022 and held it in 4 quarters. The position peaked at $30K in Q3 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

  • Fort Baker Capital Management reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
  • Fort Baker Capital Management sold 245,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $20.5K.
  • Fort Baker Capital Management first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q2 2022 and held it in 4 quarters.
  • Fort Baker Capital Management's LAVA Medtech Acquisition Corp. Warrants position peaked at $30K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Fort Baker Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.